Previous
LENALID-10-MG

Lenalid 10MG

$62.00
Next

Lenshil 10mg Capsule

$74.00
lenshil-10-mg

Sorafekast

$26.00

Active Ingredient (Generic Name) Sorafenib 200mg
Category Oncology
Manufacturer Aprazer Healthcare Pvt. Ltd.
Packaging
30 Tablets in a pack
Delivery Time 6 to 15 Days
Trust Badge Image

Description

BDR Pharmaceuticals International Pvt. Ltd. produces Sorafekast 200mg. Primary kidney cancer, advanced primary liver cancer, and thyroid cancer are among the conditions for which it is authorised.

Because of its capacity to combat malignancies of the kidney, liver, and thyroid, sorafekast (sorafenib) has increased cancer survival in these patients. Sorafekast 200 mg (sorafenib) is well-known for its anti-tumor characteristics, which include inhibiting tumour cell proliferation and reducing blood supply to tumour cells (tumour angiogenesis). Additionally, it accelerates the process of cell self-destruction (Apoptosis).
Sorafekast (sorafenib) is used to treat a variety of cancers, including kidney cancer (advanced renal cell carcinoma (RCC)).
Unresectable hepatocellular carcinoma (HCC) of the liver
Thyroid

Reviews

There are no reviews yet.

Be the first to review “Sorafekast”

Your email address will not be published.